-
Experts: Watch Apple's 'Cash Cow,' Position Of Technical Strength During Earnings
Monday, April 27, 2015 - 3:30pm | 323Read More...Apple Inc. (NASDAQ: AAPL) reports earnings on Monday afternoon, and is the focus of the equity world. In interviews with Benzinga, two experts discussed what they're watching when the company reveals its second quarter numbers. Thomas Carr, CEO of Dr.Stoxx.com, said he'll be tracking...
-
3 Technical Traders Prepare For Amazon's Earnings
Thursday, January 29, 2015 - 4:35pm | 367Read More...Amazon.com, Inc. (NASDAQ: AMZN) reports earnings after the close on Thursday and three technical traders told Benzinga what they think of the stock. CMT Christian Tharp thought that Amazon “has major support at $185 dating back to May of last year,” but that resistance forms...
-
Technical Analyst Weighs In On Alibaba
Thursday, January 29, 2015 - 9:10am | 197Read More...Technical analyst Rod David weighed in on Alibaba Group Holding Ltd (NYSE: BABA) regarding the company's stock movement. David told Benzinga, "The decline from November's peak has extended into January. It is a classic downtrend, defined as a series of alternating lower...
-
How 3 Technical Experts Are Preparing For Facebook Earnings
Wednesday, January 28, 2015 - 4:15pm | 340Read More...Three technical traders spoke to Benzinga about how they are preparing for the Facebook Inc (NASDAQ: FB) earnings announcement. Rod David noted that “December's high filled the gap back to October's high close. The drop since then attacked November's interim low.”...
-
Traders React To Intel's Q4 Earnings
Friday, January 16, 2015 - 5:22pm | 212Read More...Intel Corporation (NASDAQ: INTC) beat Q4 earnings expectations Thursday and the stock was up modestly by Friday afternoon. Trader Rod David asked: “Is [hedge fund manager] Jim Chanos looking at the massive, toppish, Descending Triangle that defines December's price action into January...
-
GW Pharmaceuticals Opens Lowers, Has Huge Recovery
Thursday, January 8, 2015 - 2:24pm | 281Read More...Marketfy Mavens Alan Brochstein and Rod David commented on GW Pharmaceuticals PLC (ADR) (NASDAQ: GWPH) following the company’s disappointing drug trial news. Brochstein noted that "the market is initially focused upon the setback," however, "the company also announced...

